Micronutrients & recovery
Omega-3 fatty acid supplementation (specifically DHA) shows promise in preclinical models for reducing beta-amyloid and oxidative stress, but current clinical evidence is insufficient to recommend it for the general prevention or treatment of cognitive frailty or dementia.
Focus on obtaining Omega-3 fatty acids through dietary sources like fish rather than supplements for general cognitive health. Do not use Omega-3 supplements as a primary treatment or prevention strategy for dementia, as current clinical evidence is insufficient to support this use, unless you have a specific deficiency.
The evidence from experimental studies on the beneficial effects of omega-3 PUFA supplementation is insufficient to recommend its implementation in the general population, either at the level of prevention or treatment for cognitive frailty or for established dementia.
Why this rating
Preclinical evidence is strong, but clinical evidence is explicitly stated as insufficient for general recommendation.
Source
Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
María Elena Gómez-Gómez et al. · International Journal of Molecular Sciences · 2019
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →